These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7928812)

  • 1. Comparative efficacies of imipenem, oxacillin and vancomycin for therapy of chronic foreign body infection due to methicillin-susceptible and -resistant Staphylococcus aureus.
    Schaad HJ; Chuard C; Vaudaux P; Rohner P; Waldvogel FA; Lew DP
    J Antimicrob Chemother; 1994 Jun; 33(6):1191-200. PubMed ID: 7928812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.
    Vaudaux P; Francois P; Bisognano C; Schrenzel J; Lew DP
    Antimicrob Agents Chemother; 2002 May; 46(5):1503-9. PubMed ID: 11959588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus.
    Vaudaux P; Francois P; Bisognano C; Li D; Lew DP; Schrenzel J
    J Antimicrob Chemother; 2003 Jul; 52(1):89-95. PubMed ID: 12775678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus.
    Schaad HJ; Chuard C; Vaudaux P; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1703-10. PubMed ID: 7985998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection.
    Schaad HJ; Bento M; Lew DP; Vaudaux P
    BMC Infect Dis; 2006 Apr; 6():74. PubMed ID: 16608512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations.
    Chuard C; Herrmann M; Vaudaux P; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2611-6. PubMed ID: 1810196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.
    Lucet JC; Herrmann M; Rohner P; Auckenthaler R; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2312-7. PubMed ID: 2128441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Cagni A; Chuard C; Vaudaux PE; Schrenzel J; Lew DP
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1655-60. PubMed ID: 7486895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G; White R; Friedrich L
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the in-vitro and in-vivo efficacy of FK037, vancomycin, imipenem and nafcillin against staphylococcal species.
    Climo MW; Markowitz SM; Williams DS; Hale-Cooper CG; Archer GL
    J Antimicrob Chemother; 1997 Jul; 40(1):59-66. PubMed ID: 9249205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence, frequency and resistance characteristics of methicillin-oxacillin resistant Staphylococcus aureus strains in Germany].
    Voss A; Machka K; Lenz W; Milatovic D
    Dtsch Med Wochenschr; 1992 Dec; 117(50):1907-12. PubMed ID: 1459021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Vaudaux P; Gjinovci A; Bento M; Li D; Schrenzel J; Lew DP
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3789-93. PubMed ID: 16127054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains.
    Sakoulas G; Gold HS; Venkataraman L; DeGirolami PC; Eliopoulos GM; Qian Q
    J Clin Microbiol; 2001 Nov; 39(11):3946-51. PubMed ID: 11682512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of clindamycin, imipenem, oxacillin and vancomycin in the infected granuloma pouch model.
    Brauner E; Gorbach S; Davey P
    J Antimicrob Chemother; 1989 Jun; 23(6):891-8. PubMed ID: 2759932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.
    Lemaire S; Olivier A; Van Bambeke F; Tulkens PM; Appelbaum PC; Glupczynski Y
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2797-805. PubMed ID: 18519727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fosfomycin-daptomycin and other fosfomycin combinations as alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Garrigós C; Murillo O; Lora-Tamayo J; Verdaguer R; Tubau F; Cabellos C; Cabo J; Ariza J
    Antimicrob Agents Chemother; 2013 Jan; 57(1):606-10. PubMed ID: 23089756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
    Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
    BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus.
    Chandrasekar PH; Levine DP; Price S; Rybak MJ
    J Antimicrob Chemother; 1988 Apr; 21(4):461-9. PubMed ID: 3378959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
    Pillai SK; Wennersten C; Venkataraman L; Eliopoulos GM; Moellering RC; Karchmer AW
    Clin Infect Dis; 2009 Oct; 49(8):1169-74. PubMed ID: 19769538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug-resistance of staphylococcus aureus and detection of mecA gene in all strains isolated from children in Hangzhou].
    Hua CZ; Li JP; Yu HM; Li S; Ye H; Shang SQ
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):360-3. PubMed ID: 16780714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.